Last edition
News about "BNCT Cancer Therapy "
TAE Life Sciences and Stella Pharma to Commercialize BPA for BNCT Cancer Therapy
The collaboration objectives include extensive international cooperation in the development and commercialization of BNCT and BPA across the USA and Europe with clinical trials anticipated to begin in 2026.
BNCT Cancer Therapy | 14/11/2024 | By Aishwarya | 563
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members